Zacks Investment Research lowered shares of Caretrust REIT (NASDAQ:CTRE) from a hold rating to a sell rating in a research note issued to investors on Monday.
According to Zacks, “CareTrust REIT, Inc. is a real estate investment trust. It is primarily engaged in the ownership, acquisition and leasing of healthcare-related properties. The Company leases healthcare facilities to healthcare operators in triple-net lease arrangements. CareTrust REIT, Inc. is based in United States. “
A number of other research analysts have also recently weighed in on CTRE. Stephens set a $19.00 target price on Caretrust REIT and gave the company a buy rating in a report on Friday, January 12th. Capital One Financial reiterated an equal weight rating and issued a $21.00 target price on shares of Caretrust REIT in a report on Sunday, October 22nd. Stifel Nicolaus reiterated a hold rating and issued a $19.00 target price (up previously from $17.00) on shares of Caretrust REIT in a report on Thursday, November 9th. BidaskClub cut Caretrust REIT from a hold rating to a sell rating in a report on Saturday, December 2nd. Finally, BMO Capital Markets restated a hold rating and set a $20.00 price objective on shares of Caretrust REIT in a research note on Thursday, November 9th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $19.78.
Shares of Caretrust REIT (CTRE) traded up $0.18 during trading on Monday, reaching $15.53. The company had a trading volume of 845,793 shares, compared to its average volume of 706,553. Caretrust REIT has a 52-week low of $14.71 and a 52-week high of $19.86. The firm has a market capitalization of $1,170.00, a PE ratio of 33.76, a P/E/G ratio of 2.40 and a beta of 0.67. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.
Caretrust REIT (NASDAQ:CTRE) last issued its earnings results on Wednesday, November 8th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.29 by ($0.01). Caretrust REIT had a net margin of 25.68% and a return on equity of 5.76%. The firm had revenue of $32.90 million during the quarter, compared to analyst estimates of $32.91 million. During the same quarter in the previous year, the business posted $0.28 EPS. Caretrust REIT’s revenue was up 21.4% compared to the same quarter last year. analysts predict that Caretrust REIT will post 1.16 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. Shareholders of record on Friday, December 29th were paid a dividend of $0.185 per share. This represents a $0.74 dividend on an annualized basis and a dividend yield of 4.76%. The ex-dividend date was Thursday, December 28th. Caretrust REIT’s dividend payout ratio is presently 160.87%.
Institutional investors and hedge funds have recently modified their holdings of the business. Riverhead Capital Management LLC lifted its stake in shares of Caretrust REIT by 90.7% during the second quarter. Riverhead Capital Management LLC now owns 5,529 shares of the real estate investment trust’s stock worth $103,000 after purchasing an additional 2,629 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Caretrust REIT by 7.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,277 shares of the real estate investment trust’s stock worth $116,000 after purchasing an additional 437 shares in the last quarter. Ameritas Investment Partners Inc. lifted its stake in shares of Caretrust REIT by 18.2% during the second quarter. Ameritas Investment Partners Inc. now owns 6,329 shares of the real estate investment trust’s stock worth $117,000 after purchasing an additional 975 shares in the last quarter. Pinebridge Investments L.P. lifted its stake in shares of Caretrust REIT by 10.7% during the second quarter. Pinebridge Investments L.P. now owns 9,558 shares of the real estate investment trust’s stock worth $177,000 after purchasing an additional 920 shares in the last quarter. Finally, Schroder Investment Management Group acquired a new position in shares of Caretrust REIT during the second quarter worth about $183,000. Institutional investors own 91.15% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/01/19/caretrust-reit-ctre-downgraded-by-zacks-investment-research-to-sell.html.
Caretrust REIT Company Profile
CareTrust REIT, Inc is a self-administered, self-managed real estate investment trust. The Company is engaged in the ownership, acquisition and leasing of healthcare-related properties. It makes investments in healthcare-related real estate assets. As of December 31, 2016, its real estate portfolio included 154 skilled nursing facilities (SNFs), SNF Campuses, assisted living facilities and independent living facilities.
Get a free copy of the Zacks research report on Caretrust REIT (CTRE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.